Publication | Closed Access
Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Patients Co-Infected with HCV and HIV-1: The Phase 3 Astral-5 Study
36
Citations
0
References
2016
Year
Astral-5 StudyTreatment And PreventionViral HepatitisAntiviral TherapyHepatitisVirologyChronic Viral InfectionAntiviral DrugHivMedicinePhase 3
No additional data available for this publication yet. Check back later!